StockData
Arvinas, Inc. logo

Arvinas, Inc. (ARVN) stock

ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$6.76−0.06 (-0.81%)

Close on Nov 18, 2026Market cap $442.34MP/E 42.3Yield –

Arvinas market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Arvinas's market cap was $451.22M on Nov 11, 2026, against $891.02M a year earlier. Over the last 5 years it ranged from $451.22M to $4.33B, with a median of $1.39B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$451.22M-46.3%
2025Dec 31, 2025$839.69M-36.2%
2024Dec 31, 2024$1.32B-41.8%
2023Dec 29, 2023$2.26B+24.4%
2022Dec 30, 2022$1.82B-58.0%
2021Dec 31, 2021$4.33B+27.3%
2020Dec 31, 2020$3.41B+150.6%
2019Dec 31, 2019$1.36B+2771.3%
2018Dec 31, 2018$47.33M–

More Arvinas figures

See a number that looks wrong?